FORT LAUDERDALE, Fla., April 27, 2004 (PRIMEZONE) -- Tekron Inc. (OTCBB:TKRN) is pleased to announce the acquisition of a 50% capital interest in Bioenergy.
Bioenergy is an Italian corporation based in Milan, Italy. The company's technology enables human and animal organic waste to be converted into commercially viable energies through a biogas. This biogas is then used to produce electricity or heat energy. The technology further produces a usable byproduct in the form of a fertilizer.
Dr. Luciano Zoia and Dr. Gianofranco Ceroni, both of Bioenergy, will be conducting relevant studies and planning for the Provincial Government of Canada beginning in May 2004. These projects will produce substantial income for the Company.
Dr. Zoia will be joining Tekron as the Chief Scientific Officer for the Company.
Bioenergy of Italy has agreed to sell Tekron 50% of its capital shares. The two companies will participate in a 50/50 joint venture to form a Canadian subsidiary of Bioenergy. The Canadian subsidiary will rapidly move forward in pursuing environmentally friendly projects that exploit the company's technology.
Alan Hetherington, Vice President and Chief Operating Officer of Tekron, states, "I am extremely pleased that Dr. Zoia and Bioenergy have chosen Tekron for an exclusive arrangement to market the company's innovative and environmentally friendly technology."
About Tekron Inc.:
Tekron Inc. is a holding company acquiring interests in high technology and medical and environmental biotechnology companies.
This information contains certain forward-looking statements and information relating to the Company that are based on the beliefs of the Company or management as well as assumptions made by and information currently available to the Company or management. When used in this document, the words "anticipate," "believe," "estimate," "expect," "intend" and similar expressions, as they relate to the Company or its management, are intended to identify forward-looking statements. Such statements reflect the current view of the Company regarding future events and are subject to certain risks, uncertainties and assumptions, including the risks and uncertainties noted. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those described herein as anticipated, believed, estimated, expected or intended. In each instance, forward-looking information should be considered in light of the accompanying meaningful cautionary statements herein.